New Horizons in Oncology for the Kingdom of Saudi Arabia
Saudi Designed and Manufactured Precision Cancer Medicines
About Immuno-Oncology:GULF
Transforming the Biotechnology Landscape in Saudi Arabia
- IO:GULF is an oncology medicines biotechnology project seeking funding within the Kingdom of Saudi Arabia.
- Fully aligned to Vision 2030 and the National Biotechnology Strategy.
- Created by industry experts from Oxford, UK.
- IO:GULF will leverage it's co-founders unique clinical, scientific and commercial skills.
- Establishing a locally headquartered research and development company focused on creating new precision oncology medicines.
- A business designed to enter the global pharmaceutical market.
- Tailored to the genetic profile of the Saudi Arabian population, whilst capturing a global market share.
- IO:GULF will become a strategic asset for Saudi Arabia, supporting and shaping the Kingdom's vision of being a global pharmaceutical powerhouse.